MedPath

Caffeine

Generic Name
Caffeine
Brand Names
Anacin, Arthriten Inflammatory Pain, Ascomp, Bc Arthritis, Bc Original Formula, Cafcit, Diurex, Dvorah, Esgic, Exaprin, Excedrin, Excedrin Tension Headache, Fioricet, Fioricet With Codeine, Fiorinal, Goody's Extra Strength, Goody's Headache Relief Shot, Goody's PM, Midol Complete, Midol Cramps & Bodyaches, Migergot, Norgesic, Norgesic Forte, Orbivan, Orphengesic, Pamprin Max Formula, Peyona, Stanback Headache Powder Reformulated Jan 2011, Trezix, Trianal, Trianal C, Triatec, Triatec-8, Vanatol, Vanatol S, Vanquish, Vivarin, Peyona (previously Nymusa), Gencebok
Drug Type
Small Molecule
Chemical Formula
C8H10N4O2
CAS Number
58-08-2
Unique Ingredient Identifier
3G6A5W338E
Background

Caffeine is a drug of the methylxanthine class used for a variety of purposes, including certain respiratory conditions of the premature newborn, pain relief, and to combat drowsiness. Caffeine is similar in chemical structure to Theophylline and Theobromine. It can be sourced from coffee beans, but also occurs naturally in various teas and cacao beans, which are different than coffee beans. Caffeine is also used in a variety of cosmetic products and can be administered topically, orally, by inhalation, or by injection.

The caffeine citrate injection, used for apnea of the premature newborn, was initially approved by the FDA in 1999. According to an article from 2017, more than 15 million babies are born prematurely worldwide. This correlates to about 1 in 10 births. Premature birth can lead to apnea and bronchopulmonary dysplasia, a condition that interferes with lung development and may eventually cause asthma or early onset emphysema in those born prematurely. Caffeine is beneficial in preventing and treating apnea and bronchopulmonary dysplasia in newborns, improving the quality of life of premature infants.

Indication

Caffeine is indicated for the short term treatment of apnea of prematurity in infants and off label for the prevention and treatment of bronchopulmonary dysplasia caused by premature birth. In addition, it is indicated in combination with sodium benzoate to treat respiratory depression resulting from an overdose with CNS depressant drugs. Caffeine has a broad range of over the counter uses, and is found in energy supplements, athletic enhancement products, pain relief products, as well as cosmetic products.

Associated Conditions
Acute Pain, Chronic Lung Disease of Prematurity, Common Cold, Dyspepsia, Fatigue, Fever, Flu caused by Influenza, Headache, Menstrual Pain, Myalgia, Pain, Pain caused by Rheumatism, Primary apnea of premature newborns, Respiratory Depression, Somnolence, Tension Headache, Toothache, Under-eyes Dark Circles, Vascular Headaches, Moderate Pain
Associated Therapies
Analgesia, Antacid therapy, Athletic Performance

Chicago Social Drinking Project

Not Applicable
Recruiting
Conditions
Alcoholism
Interventions
First Posted Date
2009-08-19
Last Posted Date
2024-01-29
Lead Sponsor
University of Chicago
Target Recruit Count
800
Registration Number
NCT00961792
Locations
🇺🇸

Clinical Addictions Research Laboratory, Chicago, Illinois, United States

AZD2066 Cocktail Study

First Posted Date
2009-06-30
Last Posted Date
2009-10-27
Lead Sponsor
AstraZeneca
Target Recruit Count
15
Registration Number
NCT00930306
Locations
🇬🇧

Research Site, Manchester, United Kingdom

Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain

Phase 2
Completed
Conditions
Cancer
Pain
Interventions
Drug: Normal saline
Drug: Caffeine
First Posted Date
2009-04-10
Last Posted Date
2011-03-29
Lead Sponsor
Korea Research Foundation
Target Recruit Count
41
Registration Number
NCT00879775
Locations
🇰🇷

Korea University Guro Hospital, Seoul, Korea, Republic of

🇰🇷

National Health Insurance Corporation Ilsan Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of

Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?

Phase 4
Completed
Conditions
Atherosclerosis
Cardiovascular Disease
Interventions
First Posted Date
2009-02-25
Last Posted Date
2009-10-01
Lead Sponsor
Radboud University Medical Center
Target Recruit Count
8
Registration Number
NCT00851175
Locations
🇳🇱

RUNMC, Nijmegen, Netherlands

Effect of Multiple Doses of AZD6280 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2)

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2009-01-16
Last Posted Date
2009-07-31
Lead Sponsor
AstraZeneca
Target Recruit Count
24
Registration Number
NCT00824057
Locations
🇬🇧

Research Site, London, United Kingdom

Caffeine Versus Placebo for Spinal Headaches

Not Applicable
Completed
Conditions
Post Dural Puncture Headache
Interventions
Drug: Caffeine
Drug: saline
First Posted Date
2008-12-17
Last Posted Date
2013-10-29
Lead Sponsor
United States Naval Medical Center, Portsmouth
Target Recruit Count
21
Registration Number
NCT00809627
Locations
🇺🇸

Emergency Department, Naval Medical Center Portsmouth, Portsmouth, Virginia, United States

Determine the Effect of Multiple Doses of AZD7325, CYP Study

Phase 1
Completed
Conditions
Healthy Volunteer
Interventions
First Posted Date
2008-11-13
Last Posted Date
2008-11-13
Lead Sponsor
AstraZeneca
Target Recruit Count
24
Registration Number
NCT00790114

Efficacy of ONE A DAY Weightsmart Advanced Versus Caffeine and Placebo on Energy Expenditure, Thermogenesis and Perceived Energy Levels in Women.

Phase 4
Completed
Conditions
Energy Expenditure
Interventions
Drug: Placebo
Drug: Caffeine
Dietary Supplement: One-A-Day Weight S.A. (Multi-Vitamins, BAY94-9350)
First Posted Date
2008-10-29
Last Posted Date
2018-12-19
Lead Sponsor
Bayer
Target Recruit Count
22
Registration Number
NCT00781586

The Impact of Caffeine on Brachial Endothelial Function in Healthy Subjects and in Patients With Ischemic Heart Disease

Phase 3
Completed
Conditions
Coronary Disease
Interventions
Drug: Placebo
Drug: Caffeine
First Posted Date
2007-11-28
Last Posted Date
2010-02-25
Lead Sponsor
Sheba Medical Center
Target Recruit Count
80
Registration Number
NCT00564824
Locations
🇮🇱

Heart Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel

Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients

Phase 2
Completed
Conditions
Cocaine Related Disorders
Interventions
First Posted Date
2007-07-02
Last Posted Date
2012-03-01
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
85
Registration Number
NCT00495092
Locations
🇪🇸

Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain

© Copyright 2025. All Rights Reserved by MedPath